Introduction {#Sec1}
============

The Gram-negative bacterium *Vibrio cholerae*, as a species, is part of the normal flora of the aquatic ecosystems worldwide, but many strains of the species can cause severe disease in humans. Strains of *V. cholerae* belonging to the serogroups O1 and O139 are the causative agent of cholera, an epidemic diarrheal disease, which still affects millions of people in most developing countries of Asia, Africa, and Latin America \[[@CR1]\]. In Europe, cholera infections are found only rarely, and these patients have a history of traveling from countries where the disease is endemic. In Germany, a total of 17 travel-associated cases were notified and confirmed since 2001 (Robert Koch Institute, <http://www3.rki.de/SurvStat/>).

However, besides the toxigenic O1 and O139 serogroups, *V. cholerae* strains belonging to more than 200 serogroups are widespread in aquatic environments \[[@CR2], [@CR3]\]. A number of reports have demonstrated that some strains of these serogroups can cause diarrheal diseases or local infections, but do not have the ability to cause epidemic outbreaks \[[@CR3], [@CR4]\]. Whereas the major virulence factors of toxigenic *V. cholerae* O1 and O139 are known to be the cholera toxin (CT) and the toxin-coregulated pilus (TCP), a number of accessory virulence factors have been identified which play a synergistic role in the infection process \[[@CR5], [@CR6]\]. These factors include the mannose-sensitive hemagglutinin pilus (MSHA) \[[@CR7]\], the repeats-in-toxin (RTX) toxin cluster \[[@CR8], [@CR9]\], outer membrane proteins (OmpU) \[[@CR10], [@CR11]\], and hemolysins \[[@CR2], [@CR5], [@CR7]\]. Genes for some of these accessory virulence factors are present in non-O1, non-O139 strains as well and are assumed to play a role in their survival in the natural environment \[[@CR7]\].

In central Europe, *V. cholerae* belonging to the non-O1, non-O139 serogroups occur in the coastal waters of the North Sea and Baltic Sea \[[@CR12], [@CR13]\], but have also been found in some alkaline lakes \[[@CR14], [@CR15]\]. Global warming and climate change is expected to increase the water surface temperatures of seas and lakes of central Europe and has stimulated forecasts that non-cholera *Vibrio* infections will increase, especially in hot summer periods \[[@CR16]\]. Epidemiological information on *Vibrio* diseases are, up to now, limited, as no systematic monitoring programs for *Vibrio* species and no surveillance of *Vibrio* infections in clinical settings have been undertaken.

So far, only sporadic cases with *V. cholerae* non-O1, non-O139 infections have been reported in Germany and Austria \[[@CR15], [@CR17], [@CR18]\]. These included a few cases of diarrhea in travelers returning from foreign countries and had been suspected to be cholera, and some cases of local infections, including otitis or wound infection. The latter cases were caused by contact with contaminated seawater after recreational activities like bathing. *V. cholerae* isolates from these cases probably belong to the autochthonous flora of the water.

The aim of this study was to elucidate the phenotypic and genotypic characteristics of clinical isolates from German and Austrian patients with a special focus on strains originating from sea and lake waters. To characterize the pathogenic potential of *V. cholerae* non-O1, non-O139 strains, a number of virulence genes were investigated, including those encoding CT and TCP normally carried by O1 and O139 strains, but also occasionally found in non-O1, non-O139 strains. In addition, pathogenicity-related phenotypic traits including hemolytic activity, serum resistance, and biofilm formation were assessed. Strains were further characterized using *rpoB* sequencing and whole-cell matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) analysis, and the discriminative potential of these techniques at the strains level was evaluated.

Materials and methods {#Sec2}
=====================

Bacterial strains {#Sec3}
-----------------

A total of 18 *V. cholerae* non-O1, non-O139 isolates from German and Austrian patients and five *V. cholerae* O1 or O139 control strains were used in this study (Table [1](#Tab1){ref-type="table"}). Recent strains were obtained from the Robert Koch Institute, Berlin, or were collected by the Landesamt für Gesundheit und Soziales (LAGuS), Rostock, Germany, and Österreichische Agentur für Gesundheit und Ernährungssicherheit (AGES), Vienna, Austria. Two strains (VN-0168, VN-0169) were isolated from a patient with *V. vulnificus* coinfection. *V. cholerae* O1 and O139 reference strains were used as controls to validate the tests. One strain, VN-0309 (veterinary isolate from a doctor fish, *Garra rufa*), showed a strong and robust biofilm formation, and was used in the biofilm assay as a reference strain.Table 1List of non-O1, non-O139 *Vibrio cholerae* strains and control O1 or O139 strains used in this studyStrainYear of isolationType of infectionOriginSourceVN-01682010wound infection\*GermanyLAGuSVN-01692010wound infection\*GermanyLAGuSVN-02102011diarrhea/travel diseaseTunisiaRKIVN-02112011diarrhea/travel diseaseItalyRKIVN-02971995otitisGermanyBfRVN-02981995otitisGermanyBfRVN-02991996diarrhea/travel diseaseTunisiaBfRVN-03001999diarrhea, peritonitisunknownBfRVN-03012000otitisAustriaBfRVN-03022012diarrheaGermanyRKIVN-03032012otitisHungaryRKIVN-03042012diarrhea/travel diseaseEgyptRKIVN-03052012otitisGermanyRKIVN-03072012otitisGermanyRKIVN-03082012diarrhea/travel diseaseRomaniaRKIVN-03132000otitisAustriaAGESVN-03142005otitisAustriaAGESVN-03152011diarrhea/travel diseaseCubaAGESControl strains NIH35A3 (O1)1941diarrheaIndiaBfR NIH41 (O1)1941diarrheaIndiaBfR 1576 (O1)1959diarrheaThailandBfR, \[[@CR42]\] 1360 (O1)1959diarrheaThailandBfR, \[[@CR42]\] MO45 (O139)1992diarrheaIndiaBfR\*Isolates from the same patientAGES: Austrian Agency for Health and Food Safety, Vienna, AustriaBfR: Federal Institute for Risk Assessment, Berlin, GermanyLAGuS: State Office for Health and Social Affairs, Rostock, GermanyRKI: Robert Koch Institute, Berlin, Germany

Species identities of all strains were confirmed by standard biochemical assays, species-specific polymerase chain reaction (PCR) targeting the *toxR* gene \[[@CR19]\], sequencing of a fragment of the *rpoB* gene \[[@CR20]\], and MALDI-TOF MS analysis.

Strain cultivation {#Sec4}
------------------

Strains were routinely cultivated in Luria-Bertani (LB) medium (Merck, Darmstadt, Germany) at 37 °C. Mannose fermentation was carried out by pregrowing strains on LB agar for 24 h at 37 °C. Five milliliters of mannose fermentation broth (1 % mannose, 0.0075 % bromothymol blue, 1 % peptone, 0.5 % NaCl, pH 7.4) were inoculated using an inoculating needle, incubated at 37 °C, and examined for mannose fermentation at 24 h and after 5 days. Sucrose fermentation was investigated in the same medium by replacing mannose with sucrose. The blood agar base (Mast Diagnostics, Rheinfeld, Germany) used for the qualitative hemolysis test contained 5 % defibrinated sheep blood.

MALDI-TOF MS analysis {#Sec5}
---------------------

Bacteria were cultivated on LB agar plates overnight at 37 °C. Two different sample preparation procedures were employed. For direct transfer, a single colony of fresh overnight cultures was transferred onto a stainless steel target using a sterile toothpick and overlaid with matrix solution containing 10 mg/ml α-cyano-4-hydroxycinnamic acid in acetonitrile, water, and trifluoroacetic acid (50:47.5:2.5, v/v). In the second procedure, bacterial proteins were extracted from cells using ethanol and formic acid according to the manufacturer's protocol (Bruker Daltonik, Bremen, Germany). All samples were spotted in triplicate.

MALDI-TOF MS analysis was performed using a Microflex LT system (Bruker Daltonik) mass spectrometer following the manufacturer's settings. Captured spectra were analyzed using automated control and the Bruker Biotyper 3.0 software and library. Bacterial test standard (BTS; part no. 255343, Bruker Daltonik) was used for calibration and validation. Criteria used for analysis were as recommended by the manufacturer for species identification.

PCR genotyping {#Sec6}
--------------

Genomic DNA was extracted using the RTP Bacteria DNA Kit from STRATEC Molecular, Berlin, Germany. PCR reactions were performed using a Mastercycler EP Gradient (Eppendorf, Hamburg, Germany) in a volume of 25 μl with 1× PCR buffer (2 mM MgCl~2~), 0.2 mM of each dNTP, 0.2 μM of each primer, and 1.5 U of Dream Taq DNA Polymerase (Fermentas, St. Leon-Rot, Germany). The PCR primers, target genes, and amplicon sizes are shown in Table [2](#Tab2){ref-type="table"}.Table 2Polymerase chain reaction (PCR) primers, targets, and amplicon sizes used for genotypingTarget genePrimerSequenceAmplicon size (bp)References*rfb* O139 clusterO139FAGCCTCTTTATTACGGGTGG\[[@CR43], [@CR44]\]*rfb* O139 clusterO139RGTCAAACCCGATCGTAAAGG449\[[@CR43], [@CR44]\]*rfb* O1 clusterO1FGTTTCACTGAACAGATGGG\[[@CR43], [@CR44]\]*rfb* O1 clusterO1RGGTCATCTGTAAGTACAAC192\[[@CR43], [@CR44]\]*ctx*ctxA1CTCAGACGGGATTTGTTAGGCACG\[[@CR2]\]*ctx*ctxA2TCTATCTCTGTAGCCCCTATTACG301\[[@CR2]\]*toxR*UtoxFGASTTTGTTTGGCGYGARCAAGGTT\[[@CR19]\]*toxR*VctoxRGGTTAGCAACGATGCGTAAG640\[[@CR19]\]*rpoB*CM32b-FCGGAACGGCCTGACGTTGCAT\[[@CR20]\]*rpoB*1110F-RGTAGAAATCTACCGCATGATG984\[[@CR20]\]*rpoB*1661F\*TTYATGGAYCARAACAACCC--\[[@CR20]\]*rpoB*1783b\*GGACCTTYAGGNGTTTCGAT--\[[@CR20]\]*hlyA class/ET*hlyA-489FGGCAAACAGCGAAACAAATACC727/738\[[@CR5], [@CR6]\]*hlyA ET*hlyA-744FGAGCCGGCATTCATCTGAAT481\[[@CR5], [@CR6]\]*hlyA class/ET*hlyA-1184RCTCAGCGGGCTAATACGGTTTA\[[@CR5], [@CR6]\]*tcpA*tcpA-F_Class-ETCACGATAAGAAAACCGGTCAAGAG\[[@CR5], [@CR6]\]*tcpA class*tcpA-R_classTTACCAAATGCAACGCCGAATG620\[[@CR5], [@CR6]\]*tcpA ET*tcpA-R_ETAATCATGAGTTCAGCTTCCCGC453\[[@CR5], [@CR6]\]TTSS *vcsC2*TTSS_vcsC2-ACGTTACCGATGCTATGGGT\[[@CR2]\]TTSS *vcsC2*TTSS_vcsC2-BAGAAGTCGGTTGTTTCGGTAA535\[[@CR2]\]TTSS *vcsN2*TTSS_vcsN2-ACAGTTGAGCCAATTCCATT\[[@CR2]\]TTSS *vcsN2*TTSS_vcsN2-BGACCAAACGAGATAATG484\[[@CR2]\]TTSS *vspD*TTSS_vspD-AAACTCGAAGAGCAGAAAAAAGC\[[@CR2], [@CR31]\]TTSS *vspD*TTSS_vspD-BCTTCCCGCTTTTGATGAAATG422\[[@CR2], [@CR31]\]TTSS *vcsV2*TTSS_vcsV2-ATTTGGCTCACTTGATGGG\[[@CR2], [@CR31]\]TTSS *vcsV2*TTSS_vcsV2-BGCCACATCATTGCTTGCT742\[[@CR2], [@CR31]\]*mshA*VC0409-FATTCTCGGTATCTTGGCCGTC\[[@CR7]\]*mshA*VC0409-RACAAGCAGTTCCAGCAACCC459\[[@CR7]\]*rstR class*VC-rstR-class-FCTCATCAGCAAAGCCTCCATC\[[@CR7]\]*rstR class*VC-rstR-class-RTAGCAAATGGTATCGGCGTTG241\[[@CR7]\]*rstR ET*VC1455-FAGCCAACCAAAGAAAGGCAAT\[[@CR7]\]*rstR ET*VC1455-RTCATCTGTGGCCCATCTTCC186\[[@CR7]\]*rstR Calc*VC-rstR-calc-FCCAGCATTTCTGTTTCTTTG\[[@CR7]\]*rstR Calc*VC-rstR-calc-RGGCAACAAAGCACATTAAAG104\[[@CR7]\]*dth*VCA1111-FCAACCATGCACTAAATTGCCCThis study*dth*VCA1111-RTGGAAGTCATTACACCCACGC526This study*chxA*VC-chxA-FTGTGTGATGATGCTTCTGG\[[@CR33]\]*chxA*VC-chxA-RTTATTTCAGTTCATCTTTTCGC2000\[[@CR33]\]*rtxA*VC1451-FGATTCTTCCGTTCAAGCTCCGThis study*rtxA*VC1451-RTGGTTCAGGCTGTTGCACAC2571This study*rtxC*VC1450-FTGCAAATCTCACATTAGCGCAThis study*rtxC*VC1450-RCCACTGCACCTTTCGGATACA430This study*ompU*ompU-FACGCTGACGGAATCAACCAAAG\[[@CR2]\]*ompU*ompU-RGCGGAAGTTTGGCTTGAAGTAG869\[[@CR2]\]*zot*zot-FTCGCTTAACGATGGCGCGTTTT\[[@CR2]\]*zot*zot-RAACCCCGTTTCACTTCTACCCA947\[[@CR2]\]*ace*ace-FTAAGGATGTGCTTATGATGGACACCC\[[@CR2]\]*ace*ace-RCGTGATGAATAAAGATACTCATAGG289\[[@CR2]\]VSP-1Vch-VspI-foGCTCTCGCCAGCAAGGAGCTG\[[@CR7]\]VSP-1Vch-VspI-reCCGTCGAAGTGAACGGCGAAC1700\[[@CR7]\]VSP-2Vch-VspII-foTGCCCATTCCGCTAAGTGTTC\[[@CR7]\]VSP-2Vch-VspII-reGCAAAAGCACTGCGTAAACTG800\[[@CR7]\]\*Sequencing primers

PCR-based amplification of the *rpoB* gene and analysis of the products were conducted as described previously \[[@CR21]\]. Sequences of 871 bp encoding a part of the *rpoB* gene \[[@CR20]\] of all strains were aligned using the Accelrys Gene version 2.5 software (Accelrys Ltd., Cambridge, UK) and a dendrogram was calculated using the unweighted pair group method analysis (UPGMA) algorithm with absolute differences. Sequencing reactions were performed commercially at Eurofins MWG Operon, Ebersberg, Germany. Primers were synthesized by Metabion International AG, Planegg/Martinsried, Germany.

Hemolytic activity of bacterial cells and culture supernatants on human erythrocytes {#Sec7}
------------------------------------------------------------------------------------

Quantitative hemolysis assay was carried out as described by Bier et al. \[[@CR22]\], and each strain was tested three times. Hemolytic activities of cells and supernatant were tested separately, and an observed hemolysis of below 20 % was rated as negative.

Serum resistance {#Sec8}
----------------

The serum resistance test was carried out as described previously \[[@CR22], [@CR23]\]. Isolates that showed growth in the presence of 60--80 % human serum were classified as serum resistant. Isolates that grew in the presence of 20--40 % and 0--10 % human serum were classified as intermediate and sensitive, respectively. For Fig. [2](#Fig2){ref-type="fig"} (binary data), only strains that grew in 60--80 % serum were rated resistant.

Biofilm formation {#Sec9}
-----------------

The ability of the bacteria to form a biofilm was assessed according to Mahoney et al. \[[@CR24]\], with minor modifications. LB overnight cultures were inoculated at tenfold or hundredfold dilutions into 225 μl of Heart Infusion Broth (HIB) per well of a polystyrene microtiter plate and grown for 4 h at 37 °C with shaking at 200 rpm. Each strain was tested four times for each dilution in an experiment. The OD~590~ was measured for the determination of growth. The cultures were then expelled from the plates, which were washed twice with 250 μl of distilled water per well. Plates were dried overnight and the biofilm was fixed at 60 °C for 60 min. Following staining with 250 μl of 0.1 % crystal violet (w/v in distilled water) solution for 20 min, the dye solution was removed, the wells were washed three times with distilled water, and dried for 2 h. The dye was redissolved in 300 μl of 33 % acetic acid for 20 min, then 50 μl were removed and diluted twofold in 33 % acetic acid.

The OD~570~ was measured, and the biofilm quantified as absorbance normalized to the cell density of the initial culture (OD~590~). Biofilm formation was investigated using *V. cholerae* VN-0309 as a reference, which showed a robust biofilm formation phenotype under the test conditions. Biofilm formation of this strain determined photometrically at 570 nm after reextraction of crystal violet from fixed cells was set to 100 %. The biofilm formation was defined as none (0--10 % of biofilm activity of VN-0309), weak (11--40 %), intermediate (41--70 %), and strong (\>70 %). Strains that showed strong or intermediate biofilm formation were rated as positive for Fig. [2](#Fig2){ref-type="fig"} (binary data).

Results {#Sec10}
=======

Species determination {#Sec11}
---------------------

All strains had been routinely typed in the reference laboratory as *V. cholerae* using standard biochemical tests \[[@CR25]\]. A multiplex PCR targeting *toxR*, *ctxA*, and the *rfb* sequences specific for O1 and O139 serogroups \[[@CR19], [@CR26]\] was used for further subtyping of all *V. cholerae* isolates. While all strains were positive in the *toxR* PCR specific for *V. cholerae*, only the control strains were positive for *ctxA*. As expected, four of the toxigenic strains were positive in the O1 serogroup PCR and one toxigenic strain was positive in the O139 serogroup PCR, thus confirming the validity of the PCR tests. Further species confirmation was obtained by partial *rpoB* sequencing and MALDI-TOF MS analysis.

*rpoB* sequencing {#Sec12}
-----------------

The nucleotide sequences of an 871 bp fragment of the *rpoB* gene which has been evaluated for species identification of *Vibrio* species \[[@CR20], [@CR21]\] were determined for all 23 isolates and used for the construction of a dendrogram \[[@CR20]\]. Figure [1](#Fig1){ref-type="fig"} shows the hierarchical clustering on the basis of sequence differences. The sequences of all toxigenic strains and three non-O1, non-O139 strains were identical, the other strains showed few nucleotide exchanges, with an overall similarity of 99.4 %. Two strains (VN-0303, VN-0304) showed slightly greater differences of up to 3.4 % compared to the sequences derived from the other strains in the stretch of 871 bp and between each other. Nevertheless, alignment to databases using BlastN (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) clearly confirmed the classification of the species as *V. cholerae*. Despite the sequence variations, nearly all nucleotide exchanges were synonymous. The deduced protein sequences were identical in 20 strains, two strains possessed one amino acid (aa) difference in the stretch of 290 aa (VN-0211, VN-0303), and one strain (VN-0304) had three different aa in the protein sequence.Fig. 1Tree based on partial *rpoB* sequences created by the unweighted pair group method analysis (UPGMA) with absolute differences. Similarity is shown in percent

Bacterial identification using MALDI-TOF MS {#Sec13}
-------------------------------------------

MALDI-TOF MS using intact cells successfully identified all *V. cholerae* isolates under study to the species level with high confidence. The observed set of high-intensity species-identifying biomarker ions were tentatively assigned and included ribosomal proteins such as 50S ribosomal protein L36 (m/z 5,125), 50S ribosomal protein L32 (m/z 6,168), ribosomal protein L30 (m/z 6,455), 30S ribosomal protein S16 (m/z 9,084), DNA-binding protein HU-α (m/z 9,493) and -β (m/z 9,368), and integration host factor subunit α (m/z 10,991) and β (m/z 10,548). To determine if the method could be used for further differentiation of O1, O139 serogroups from non-O1, non-O139 serogroups, all spectra from both groups that were obtained using the direct transfer method and after the extraction of proteins from bacterial cells were compared. First, a dendrogram was created using the Biotyper software; however, there was no overall clustering of serotypes observed in this dendrogram with either sample preparation method (data not shown). In addition, the panel of spectra was screened for biomarkers that could distinguish serogroups by visual inspection using flexAnalysis software (Bruker Daltonik). Again, no reproducible biomarker ions with specificities on the serotype level were detectable. In addition, the influence of increasing the number of shots used for summed spectra from 240 shots to 2,000 shots was investigated, but without further success.

Genotyping by PCR {#Sec14}
-----------------

The presence of a number of genes usually associated with toxigenic *V. cholerae* strains were investigated in the non-O1, non-O139 strains (Table [3](#Tab3){ref-type="table"}). None of the non-O1, non-O139 strains contained the cholera toxin gene (*ctxA*) and genes of the CTX element (*zot*, *ace*). The *rstR* gene, which shows significant sequence variations and is part of the CTX filamentous phage \[[@CR27], [@CR28]\], was not present in the non-O1, non-O139 strains. Primer combinations for three *rstR* alleles (Classical, El-Tor, Calcutta) were tested. *tcpA* was tested for two alleles (Classical, El-Tor), and all non-O1, non-O139 strains were found to be negative.Table 3Results of genotypingStrain*rfb* O1*rfb* O139*ctxAtoxRacezottcpA classtcpA El-TorrstR classrstR El-TorrstR Calcutta*VSP-1VSP-2*hlyA classhlyA El-TormshAompUrtxArtxCchxAdth*TTSS *vcsC2*TTSS *vcsN2*TTSS *vspD*TTSS *vcsV2*VN-0168−−−+−−−−−−−−^a^−++−+−+−+−−−−VN-0169−−−+−−−−−−−−^a^−++−+−+−+−−−−VN-0210−−−+−−−−−−−−−++−+++++−−−−VN-0211−−−+−−−−−−−+^b^−++−−++−+++++VN-0297−−−+−−−−−−−−−++−+−+−+−−−−VN-0298−−−+−−−−−−−−−++−+−+−+−−−−VN-0299−−−+−−−−−−−−−++−−−+−+++++VN-0300−−−+−−−−−−−−^a^−++−+−+++++++VN-0301−−−+−−−−−−−−−++−−−++−−−−−VN-0302−−−+−−−−−−−−−++−−−+−+++++VN-0303−−−+−−−−−−−−−−−^c^−−−+−−−−−−VN-0304−−−+−−−−−−−−+^b^++−−++−+−−−−VN-0305−−−+−−−−−−−−−++−+−+−+−−−−VN-0307−−−+−−−−−−−−−++−+−+−+−−−−VN-0308−−−+−−−−−−−−−++−−++−+++++VN-0313−−−+−−−−−−−−−++−−−+−+−−−−VN-0314−−−+−−−−−−−−−++−−−+−+−−−−VN-0315−−−+−−−−−−−−+^b^++−+++−+++++NIH35A3+−+++++++−−−−+−++−−−+−−−−NIH41+−+++++++−−−−+−++−−−+−−−−1576+−+++++++−−−−+−++−−−+−−−−1360+−+++++++−−−−+−++−−−+−−−−MO45−+++++−+−+−+^b^+^b^−+++++−+−−−−Absence of VSP-1 and VSP-2 is demonstrated by generating PCR products of 1,700 bp and 800 bp, respectively, as primers bind to genomic sites flanking the islands^a^PCR product of ca. 3 kbp^b^No visible PCR product^c^Only 481-bp PCR product visible

*V. cholerae* strains of the seventh pandemic possess two genomic islands, VSP-1 and VSP-2, which are absent from strains of the sixth pandemic and most environmental isolates \[[@CR7]\]. The O1 classical strains used in this study were isolated during the sixth pandemic and gave the expected PCR products, with the VSP-1 and VSP-2 primers revealing the absence of the two islands. Most of the non-O1, non-O139 strains also did not possess the two islands (12 out of 18, Table [3](#Tab3){ref-type="table"}). In the remaining six strains, only one PCR assay, either the PCR assay for VSP-1 or VSP-2, gave the expected PCR products. In three of these strains (VN-0168, VN-0169, VN-0300), amplification with the VSP-1 primer yielded a PCR product of 3 kbp instead of 1.7 kbp. However, partial sequencing of the PCR amplicon confirmed that most of the VSP-1 island was absent. In three other strains, no PCR product was visible either for VSP-1 (one strain) or VSP-2 (two strains). We did not undertake any efforts to find out if parts of the pandemic islands were present in these strains. Other reports indicate that the pandemic islands are rarely found in non-O1, non-O139 strains and carry only some of the open reading frames of these islands if present \[[@CR2], [@CR7]\].

We studied all non-O1, non-O139 strains for putative accessory virulence-associated factors like the MSHA \[[@CR7]\], the RTX toxin cluster \[[@CR8], [@CR9]\], outer membrane proteins (OmpU) \[[@CR10], [@CR11]\], and hemolysins \[[@CR2], [@CR5], [@CR7]\]. All strains were negative for the PCR assay targeting the MSHA pilus, while all toxigenic strains were positive, as expected (Table [3](#Tab3){ref-type="table"}). MSHA is a type 4 pilus involved in host colonization and acts as a receptor of phages \[[@CR29]\]. Two RTX toxin-specific PCR assays were performed. One PCR which targets the *rtxA* gene encoding the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin was positive for five strains out of the 18 non-O1, non-O139 strains. In contrast, the *rtxC* PCR targeting an acyltransferase gene of the *rtx* gene cluster was positive in all 18 strains. The toxigenic O139 strain was positive for both PCR assays, whereas all classical O1 strains were negative for the two PCRs, as O1 classical strains have a deletion in the RTX gene cluster \[[@CR25]\]. The gene of the outer membrane protein OmpU was found in nine non-O1, non-O139 strains and in all toxigenic control strains.

The hemolysin gene *hlyA* was tested according to Rivera et al. \[[@CR5]\]. All non-O1, non-O139 strains were positive for the classical/El-Tor *hlyA* PCR. One strain (VN-0303) showed only one PCR fragment and was tentatively classified as negative. The same strain did not harbor the *dth* gene encoding the δ-thermostable hemolysin \[[@CR30]\], which was found in 21 out of all 23 *V. cholerae* strains used in this study.

Some virulence factors have been identified in non-O1, non-O139 strains that do not seem to be present in toxigenic strains. A type III secretion system (TTSS) system was described that shares homology to a *V. parahaemolyticus* TTSS gene cluster \[[@CR2], [@CR31]\]. Using a set of four primer pairs targeting different genes of this secretion system \[[@CR2], [@CR31]\], we identified six strains that harbor the system, while the remaining 12 non-O1, non-O139 strains and the toxigenic strains were negative. Recently, the discovery of cholix toxin was reported in *V. cholerae* strains \[[@CR32]\], which could not be found in O1, O139 strains according to Awasthi et al. \[[@CR33]\]. Using the PCR assay described in the latter publication, we could identify the *chxA* gene in three non-O1, non-O139 strains.

Phenotypical assays {#Sec15}
-------------------

Some biochemical properties can be variable between strains of the same species. Very rarely, *V. cholerae* strains are found that are sucrose negative, while the ability to utilize mannose is much more variable \[[@CR25]\]. All strains of this study were sucrose positive, while mannose fermentation was variable in the group of non-O1, non-O139 strains. Five of eighteen non-O1, non-O139 strains and all five toxigenic strains were able to ferment mannose (Table [4](#Tab4){ref-type="table"}).Table 4Phenotypic characteristics of *Vibrio cholerae* strainsStrainSucroseMannoseSerum resistanceBiofilm formationSheep blood agarHemolysis (cells)Hemolysis (supernatant)VN-0168+−sensitiveintermediate+++VN-0169+−sensitiveintermediate+++VN-0210++sensitiveintermediate+++VN-0211+−resistantweak+++VN-0297+−intermediatenone+++VN-0298+−sensitiveweak++−VN-0299+−intermediateweak+++VN-0300++sensitiveweak+++VN-0301+−intermediatestrong−++VN-0302+−sensitiveintermediate+++VN-0303+−sensitiveweak++−VN-0304+−intermediatenone++−VN-0305+−sensitiveintermediate+++VN-0307+−sensitiveweak++−VN-0308+−resistantweak+++VN-0313++resistantweak+++VN-0314++sensitiveweak+++VN-0315++sensitiveweak+++NIH35A3++sensitivenone−−+NIH41++resistantintermediate−++1576++sensitivenone−++1360++sensitivenone−++MO45++intermediatenone+++

Biofilm formation was investigated at 37 °C using *V. cholerae* VN-0309 as the reference, which showed a robust biofilm formation under the test conditions. The biofilm formation activities of all strains were rated against this reference strain. Only one strain (VN-0301) showed strong biofilm activity and six strains, including one O1 strain (NIH41), showed intermediate activity (Supplemental Fig. [S1](#MOESM1){ref-type="media"}).

The hemolytic properties of all strains were tested qualitatively on agar plates and quantitatively in a photometric assay. On sheep blood agar, the four classical O1 strains and only one non-O1, non-O139 (VN-0301) strain were not hemolytic, while all other strains were hemolysis positive. Additionally, we studied hemolysis of human erythrocytes in a quantitative approach using logarithmic growing cells and their culture supernatants separately (Supplemental Fig. [S2](#MOESM1){ref-type="media"}). In this approach, the direct contact of bacterial cells with the erythrocytes led to a complete lysis of the cells within 2 h for most of the non-O1, non-O139 strains; the hemolytic activity of one toxigenic O1 strain (NIH35A3) was low (below 20 %) and was scored as non-hemolytic. The remaining four toxigenic strains and two non-O1, non-O139 strains (VN-0211, VN-0313) were judged as positive, since they displayed hemolytic activity between 30 to 60 %. Culture supernatants of four non-O1, non-O139 strains (VN-0298, VN-0303, VN-0304, VN-0307) were scored as negative (hemolysis below 20 %), whereas that of the other strains were positive for hemolysis.

Resistance to human serum was tested by growing cells in a medium containing different concentrations of serum. Four strains, including one O1 strain, were resistant to serum, five strains showed intermediate resistance, and the remaining strains were sensitive (Supplemental Table [S1](#MOESM1){ref-type="media"}).

All phenotyping and genotyping results were merged in a binary figure (Fig. [2](#Fig2){ref-type="fig"}), in which the clinical origin of the strains is indicated. Ten non-O1, non-O139 strains were associated with local infections like otitis and wound infection (two strains), and eight strains caused organic infections leading to diarrhea. In the binary table, the O1, O139 control strains are included as well. The cluster analysis of all genotypic and phenotypic results clearly revealed that the toxigenic O1 and O139 strains form a cluster separated from the non-O1, non-O139 strains. This is due to the fact that all genotypic assays targeting the main cholera virulence factors and accessory virulence factors (*ctx*, *zot*, *ace*, *tcpA*, *rstR*, serogroups O1 and O139) were absent in the non-O1, non-O139 strains in our study. The binary data set, however, revealed an interesting result. When the nature of the clinical infection is indicated, the analysis shows that all diarrheagenic strains possess either the TTSS (three strains) or the MARTX toxin (two strains) or both virulence factors together (three strains), while the ten strains causing localized infections are negative for the respective genes. The TTSS has been shown to induce diarrhea in an animal model \[[@CR31]\] and is absent from toxigenic strains. The *rtxA* gene encoding MARTX is present in toxigenic O1, El-Tor biotype, and O139 strains, and can be found in environmental strains with high frequency \[[@CR8]\]. The negative results of the *rtxA* PCR in some non-O1, non-O139 strains means that the *rtxA* gene is (partially) absent, or that a different *rtxA* gene variant occurs. The role of the gene product of the *rtxC* gene which is present in all non-O1, non-O139 strains is, so far, unclear; it may be necessary for posttranslational activation of MARTX by acetylation \[[@CR9]\]. However, *rtxC*-negative mutants seem to produce a functional MARTX protein \[[@CR34]\].Fig. 2Grouping of isolates based on phenotypic and genotypic traits. Similarity patterns were determined by complete linkage using simple matching of binary data (BioNumerics version 6.6.4, Applied Maths, Sint-Martens-Latem, Belgium). For the simplification of interpretation, the results of *tcpA* (two alleles) and *rstR* (three alleles) are summarized in one column. О = diarrheagenic strains, Δ = strains from local infections

All other phenotypic and genotypic traits studied occur with varying frequencies in the two groups.

Discussion {#Sec16}
==========

*Vibrio* infections are rare in Germany. However, very little epidemiological information is available for these strains, as no monitoring programs or surveillance of *Vibrio* infections are carried out. In the coastal waters of Germany and in some lakes in Germany and Austria, pathogenic non-O1, non-O139 *V. cholerae* are present and were found to occasionally cause human infections \[[@CR12], [@CR15]\]. Climate warming could lead to increased *Vibrio* concentrations, especially during hot periods in summer months, thus, predictions are that *Vibrio* infections will increase in the Baltic Sea area \[[@CR16]\]. A correlation between increased *Vibrio* infections and elevated water temperatures in the Baltic has already been observed \[[@CR18]\]. In this study, 18 non-O1, non-O139 *V. cholerae* isolates were analyzed for phenotypic and genotypic traits in comparison to five toxigenic *V. cholerae* O1 or O139 strains. Some of the non-O1, non-O139 strains are from foreign countries, as they were isolated from returned travelers with diarrheal symptoms which were suspected to be caused by *V. cholerae* infections. Other strains were obtained from patients who contracted infections through recreational activities in sea and lake waters.

Species confirmation using *rpoB* sequencing and MALDI-TOF MS were undertaken and the methods were evaluated for their discriminative value below the species level. In case of *rpoB* sequencing, this can clearly be denied, as four *rpoB* sequences of non-O1, non-O139 strains were identical to the sequences of the toxigenic strains, and the remaining strains possessed a varying degree of sequence differences, although the deduced protein sequences were highly similar.

MALDI-TOF MS analyses were undertaken on a mass spectrometer developed for routine diagnostics (Bruker MALDI Biotyper). This methodology was originally developed to provide bacterial identification on the species level \[[@CR21], [@CR35], [@CR36]\]. Spectra are typically composed of highly conserved housekeeping proteins like ribosomal proteins. Therefore, it could be expected that this technique has limitations regarding the discrimination of bacteria below the species level. Nevertheless, different studies reported on the usefulness of the method for the differentiation of *Salmonella* subspecies, a limited number of *Salmonella* serotypes, Shiga-toxin-producing *Escherichia coli* serotypes, and *E. coli* pathotypes \[[@CR37]--[@CR39]\]. However, in this study, MALDI-TOF MS using the MALDI Biotyper system based on a Microflex LT machine with the evaluation criteria developed for species identification was ineffective for differentiating O1, O139 from non-O1, non-O139 isolates.

The phenotyping and genotyping of putative pathogenicity associated traits were combined in a binary table to characterize the clinical non-O1, non-O139 strains isolated from patients in our region (Fig. [2](#Fig2){ref-type="fig"}). The cluster analysis clearly separated the toxigenic strains from the non-O1, non-O139 strains, but also revealed genetic differences of the latter strains correlating with the nature of the clinical infection. The analysis showed that TTSS and *rtxA* genes were present only in non-O1, non-O139 strains of *V. cholerae* which were from diarrhea cases.

Other virulence factors like the cholix toxin gene *chxA* could be detected in strains of both clinical groups, but only with low frequency (3 out of 18 strains positive for the *chxA* gene). This toxin seems to be associated with non-O1, non-O139 strains \[[@CR33]\], though its occurrence in O1, O139 strains was described \[[@CR32]\]. The cholix toxin is an eukaryotic elongation factor-2-specific ADP-ribosyltransferase, whose function in infections is unclear. It was suggested that it may be more associated with extraintestinal infections than enterotoxicity \[[@CR33]\]. The *ompU* gene encoding an outer membrane protein, which contributes to the survival of pathogens in host organisms and is involved in resistance to antimicrobial peptides \[[@CR10], [@CR11]\], was found in both clinical groups.

Hemolysis zones are often observed on blood agar plates when non-O1, non-O139 strains are investigated \[[@CR2]\]. With one exception, all non-O1, non-O139 strains showed hemolytic activity on sheep blood agar, and most of them were hemolytic for human erythrocytes. The genotypic analysis revealed that all strains except for one possessed the El-Tor hemolysin gene *hlyA*, which is frequently observed in non-O1, non-O139 strains \[[@CR2], [@CR5]--[@CR7]\]. Another hemolysin gene, *dth*, which encodes the δ-thermostable hemolysin, similar to the *V. parahaemolyticus* hemolysin (Tdh), was present in 16 of the 18 strains. The role of this hemolysin in disease is unclear; in toxigenic O1 strains, it does not directly contribute to virulence \[[@CR30]\]. The phenotypic and genotypic results concerning the hemolytic traits of the non-O1, non-O139 strains do not indicate a difference between the two clinical groups.

Further phenotypic properties like mannose fermentation, serum resistance, or biofilm formation were found in few strains of the two clinical groups; however, the majority of strains was negative. Human serum resistance is a specific characteristic of pathogenic *V. vulnificus* strains \[[@CR22], [@CR40]\]; however, in the non-O1, non-O139 strains, that does not seem to be the case. Biofilm formation has been studied before in *V. cholerae* strains, but no clear correlation with specific virulence factors was found \[[@CR2], [@CR41]\], although biofilm formation in non-O1, non-O139 seems to be higher than in toxigenic strains.

Conclusion {#Sec17}
==========

This study was carried out to characterize virulence-related phenotypic and genotypic traits of *Vibrio cholerae* non-O1, non-O139 clinical strains isolated in central Europe in comparison to classical O1 and O139 toxigenic strains. While cases of diarrhea were mostly travel associated, ear and wound infections caused by *V. cholerae* strains may occur after direct contact to sea or lake waters in Europe. Interestingly, the study revealed that virulence factors like the type III secretion system (TTSS) and the multifunctional autoprocessing repeats-in-toxin (MARTX) toxin are not present in the latter strains, which indicates that these factors may be relevant only for intestinal infections. Non-O1, non-O139 strains are frequently found nowadays in the aquatic environment of central Europe and may increase in the future due to global warming. Because of the growing relevance to human health, fast diagnostic tools are required in order to discern environmental strains from potentially pathogenic strains. In further studies, we will analyze the prevalence of the potential marker genes analyzed in this study in environmental strains from German coastal waters collected in recent years to find out if they are of diagnostic value in this respect. Another source of possible *Vibrio* infections in Germany is seafood. While seafood consumption is increasing in Germany, most fish and fishery products are imported (<http://faostat.fao.org/site/345/default.aspx>). *V. cholerae* non-O1, non-O139 strains isolated from seafood are, so far, only tested for the *ctx* gene and the serogroups O1 and O139. Additional testing for genes encoding TTSS and MARTX should be considered.
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